Schools to Start Offering Swine Flu Shots
The city is staggering the schedule to deliver the vaccine as it becomes available. Schools with fewer than 400 students will begin next Wednesday. Schools with more than 600 students will begin Nov. 4, and the rest on Nov. 9. The vaccinations will be given by school nurses and are expected to be available for about eight weeks. Private schools that choose to participate will also receive the vaccine.
Middle and high school students can go to weekend “vaccination events” in November and December, officials said.
Children will get an injection or a nasal spray form of the vaccine, and those younger than 10 years old will need two doses to be fully protected, officials said.
Since Sunday, Israel has received 250,000 doses of vaccine. Another 100,000 doses, made by pharmaceutical firms Novartis and GSK, will arrive in Israel by the end of the month. All these doses will also include the chemical. The first doses without the chemical will arrive only in November.
.......In some parts of the US, the vaccine is hard to get...
...while Florida and California, where large concentrations of Jews reside, don't have a shortage, on the contrary...
(as Eric Phelps had predicted: ...New York, Florida, So. California, would be vaccination hubs.... and so it appears to be.)
So. California is vaccinating all its medical staff (voluntary for now), while Florida has excess vaccine quantities....
but TEXAS has a shortage!
I will let you interpret this disparity as you wish. I, however, believe it was all planned, and NOT for the benefit of the Jews.
... While European countries will definitely use ADJUVANTED vaccine.
Britain starts giving swine flu shots
Dept. of health hopes to vaccinate 11 million people in coming weeks
Full Article Here.CHICAGO (Reuters) – The U.S. government awarded $60 million to researchers and companies on Thursday to develop vaccine adjuvants — substances designed to boost the immune response and can help stretch short vaccine supplies. “The goal of these awards is to find safe new adjuvants that will boost the effectiveness of vaccines,” Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, which awarded the grants. “Adjuvants can be used not only to enhance the immune response to a vaccine and thereby offer better protection but also to extend the vaccine supply if needed, enabling more people to be vaccinated with fewer doses,” Fauci said in a statement. The five-year contracts went to six researchers, including one from Corixa Corp. of Hamilton, Montana, a unit of Britain-based drugmaker GlaxoSmithKline. Other awards went to researchers at the University of Michigan, the University of California San Diego, the University of Kansas, the University of Washington School of Medicine, and Mount Sinai School of Medicine, New York. Currently, the only vaccine adjuvant approved for use in the United States is an aluminum mixture known as alum, which is not used in flu vaccines because it does a poor job at boosting the immune response. Adjuvants are widely used in flu vaccines in Europe, including vaccines made by Glaxo and Novartis. The World Health Organization promotes the use of adjuvants because they can stretch the short supply of vaccine for H1N1 swine flu vaccine, making more shots available to needy countries. WHO says the global capacity to make influenza vaccines is about 3 billion doses a year — not enough to cover the population of 6.8 billion people.
VACTRUTH Editor’s Note: The WHO, FDA, CDC, NIH, HHS, and proponents of vaccines state that Alum, MF59 and AS03/04 adjuvants already on the market are safe and effective. What is the purpose of replacing something that apparently ‘works’ ?